Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.48 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.48 |
| ▸ | MC4R | P32245 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.44 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29085396 | 0.82 | OPRD1 (0.48) | HDAC4HDAC1MC4RMAPTKMT2A | |
| SCHEMBL14924035 | 0.80 | CYP2D6 (0.52) | HDAC4HDAC1MC4RMAPTCHRM2 | |
| SCHEMBL14924473 | 0.79 | ALDH1A1 (0.53) | MC4RMAPTKMT2AMEN1CHRM2 | |
| SCHEMBL18403967 | 0.79 | ALDH1A1 (0.53) | MC4RMAPTKMT2AMEN1CHRM2 | |
| SCHEMBL13380744 | 0.79 | MAPT (0.41) | ATMHDAC4HDAC1MAPTKMT2A | |
| SCHEMBL1013432 | 0.78 | ALDH1A1 (0.50) | ATMMAPTALDH1A1OPRD1KDM4E | |
| SCHEMBL19251271 | 0.78 | CYP2D6 (0.48) | ATMHDAC4HDAC1MC4RCHRM2 | |
| SCHEMBL18403964 | 0.78 | GAA (0.54) | HDAC4HDAC1MC4RMAPTKMT2A | |
| SCHEMBL10112423 | 0.78 | CYP2D6 (0.50) | HDAC4HDAC1MC4RKMT2AMEN1 | |
| SCHEMBL20012737 | 0.77 | CYP2D6 (0.74) | HDAC4HDAC1MC4RKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100081799-A1 | Chelating Agent | TECHNISCHE UNIVERSITAT MUNCHEN (DE) | 2010-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100081799-A1 | Chelating Agent | HRH3, C3AR1, H1-3 | ATM 4530/4885HDAC4 1700/4885HDAC1 266/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.